Digital Library
Close Browse articles from a journal
 
Search for with title:
ABCDEFGHIJKLMNOPQRSTUVWXYZ

     Journal description
       All volumes of the corresponding journal
         All issues of the corresponding volume
                                       All articles of the corresponding issues
 
                             37 results found
no title author magazine year volume issue page(s) type
1 A classical inactivated vaccine induces protection against caprine herpesvirus 1 infection in goats Tempesta, Maria
 2001
 19 28-29 p. 3860-3864
5 p.
 article
2 A model to assess the infection potential of jet injectors used in mass immunisation Hoffman, P.N
 2001
 19 28-29 p. 4020-4027
8 p.
 article
3 An open study of subcutaneous administration of inactivated hepatitis A vaccine (VAQTA®) in adults: safety, tolerability, and immunogenicity Linglöf, Thomas
 2001
 19 28-29 p. 3968-3971
4 p.
 article
4 A recombinant Semliki Forest virus particle vaccine encoding the prME and NS1 proteins of louping ill virus is effective in a sheep challenge model Morris-Downes, Margaret M
 2001
 19 28-29 p. 3877-3884
8 p.
 article
5 Assembly of synthetic peptide vaccines by chemoselective ligation of epitopes: influence of different chemical linkages and epitope orientations on biological activity Zeng, Weiguang
 2001
 19 28-29 p. 3843-3852
10 p.
 article
6 A truncated HCV core protein elicits a potent immune response with a strong participation of cellular immunity components in mice Alvarez-Obregón, Julio César
 2001
 19 28-29 p. 3940-3946
7 p.
 article
7 BBG2Na an RSV subunit vaccine candidate intramuscularly injected to human confers protection against viral challenge after nasal immunization in mice Goetsch, L
 2001
 19 28-29 p. 4036-4042
7 p.
 article
8 Corrigendum to “Xerovac: an ultra rapid method for the dehydration and preservation of live attenuated Rinderpest and Peste des Petits ruminants vaccines” Worrall, E.E
 2001
 19 28-29 p. 4086-
1 p.
 article
9 Enhancement of the immunity to foot-and-mouth disease virus by DNA priming and protein boosting immunization Shieh, Jeng-Jer
 2001
 19 28-29 p. 4002-4010
9 p.
 article
10 Erratum to “Enhanced immunogenicity of a conformational epitope of human T-lymphotropic virus type 1 using a novel chimeric peptide” [Vaccine 19 (2001) 1068–1081] Frangione-Beebe, Melanie
 2001
 19 28-29 p. 4087-
1 p.
 article
11 Evaluation of the response to a booster dose of hepatitis B vaccine in previously immunized healthcare workers Williams, James L
 2001
 19 28-29 p. 4081-4085
5 p.
 article
12 Experimental utility of rabies virus-neutralizing human monoclonal antibodies in post-exposure prophylaxis Hanlon, C.A
 2001
 19 28-29 p. 3834-3842
9 p.
 article
13 Expression of Helicobacter pylori urease subunit B gene in Lactococcus lactis MG1363 and its use as a vaccine delivery system against H. pylori infection in mice Lee, Ming Hsun
 2001
 19 28-29 p. 3927-3935
9 p.
 article
14 Gene gun-mediate DNA vaccination against foot-and-mouth disease virus Benvenisti, Luna
 2001
 19 28-29 p. 3885-3895
11 p.
 article
15 Immune responses and protection in different strains of aged mice immunized intranasally with an adjuvant-combined influenza vaccine Asanuma, Hideki
 2001
 19 28-29 p. 3981-3989
9 p.
 article
16 Immunization of mice with recombinant gp41 in a systemic prime/mucosal boost protocol induces HIV-1-specific serum IgG and secretory IgA antibodies Mantis, Nicholas J
 2001
 19 28-29 p. 3990-4001
12 p.
 article
17 Immunogenicity and reactogenicity of acellular diphtheria/tetanus/pertussis vaccines given as a pre-school booster: effect of simultaneous administration of MMR Miller, E.
 2001
 19 28-29 p. 3904-3911
8 p.
 article
18 Intranasal immunisation with influenza-ISCOM induces strong mucosal as well as systemic antibody and cytotoxic T-lymphocyte responses Sjölander, Sigrid
 2001
 19 28-29 p. 4072-4080
9 p.
 article
19 Low-dose intradermal administration of recombinant hepatitis B vaccine in children: 5-year follow-up study Kurugöl, Zafer
 2001
 19 28-29 p. 3936-3939
4 p.
 article
20 MMR vaccine in HIV-infected children — potential hazards? Goon, P
 2001
 19 28-29 p. 3816-3819
4 p.
 article
21 Modifying the cellular transport of DNA-based vaccines alters the immune response to hantavirus nucleocapsid protein Bucht, Göran
 2001
 19 28-29 p. 3820-3829
10 p.
 article
22 Mutant hepatitis B viruses: a matter of academic interest only or a problem with far-reaching implications? François, Guido
 2001
 19 28-29 p. 3799-3815
17 p.
 article
23 Nucleotide sequence analysis of varicella-zoster virus glycoprotein E epitope coding regions Shankar, Vidya
 2001
 19 28-29 p. 3830-3833
4 p.
 article
24 Optimization of DNA immunization against human cytomegalovirus Endrész, V
 2001
 19 28-29 p. 3972-3980
9 p.
 article
25 Paradoxical effects of IL-12 in leishmaniasis in the presence and absence of vaccinating antigen Noormohammadi, A.H.
 2001
 19 28-29 p. 4043-4052
10 p.
 article
26 Present anti-measles immunity in Jordan Bdour, Salwa
 2001
 19 28-29 p. 3865-3869
5 p.
 article
27 Protection of rainbow trout against infectious hematopoietic necrosis virus four days after specific or semi-specific DNA vaccination LaPatra, Scott E.
 2001
 19 28-29 p. 4011-4019
9 p.
 article
28 Protective efficacy against tuberculosis of ESAT-6 secreted by a live Salmonella typhimurium vaccine carrier strain and expressed by naked DNA Mollenkopf, Hans-Joachim
 2001
 19 28-29 p. 4028-4035
8 p.
 article
29 Prothymosin α enhances protective immune responses induced by oral DNA vaccination against pseudorabies delivered by Salmonella choleraesuis Shiau, Ai-Li
 2001
 19 28-29 p. 3947-3956
10 p.
 article
30 Recombinant hemagglutinin protein of rinderpest virus expressed in insect cells induces humoral and cell mediated immune responses in cattle Sinnathamby, G.
 2001
 19 28-29 p. 3870-3876
7 p.
 article
31 Staphylococcus aureus capsular polysaccharide type 5 conjugate and whole cell vaccines stimulate antibody responses in cattle Tollersrud, Tore
 2001
 19 28-29 p. 3896-3903
8 p.
 article
32 Tetanus toxoid loaded ‘preformed microspheres’ of cross-linked dextran Diwan, M
 2001
 19 28-29 p. 3853-3859
7 p.
 article
33 The anti-idiotypic antibody to chlamydial glycolipid exoantigen (GLXA) protects mice against genital infection with a human biovar of Chlamydia trachomatis Whittum-Hudson, Judith A
 2001
 19 28-29 p. 4061-4071
11 p.
 article
34 The effect of introduction of universal childhood hepatitis B immunization in South Africa on the prevalence of serologically negative hepatitis B virus infection and the selection of immune escape variants Hino, Keisuke
 2001
 19 28-29 p. 3912-3918
7 p.
 article
35 The first five years of universal hepatitis B vaccination in South Africa: evidence for elimination of HBsAg carriage in under 5-year-olds Tsebe, Khomotso V
 2001
 19 28-29 p. 3919-3926
8 p.
 article
36 The immune response to a DNA vaccine can be modulated by co-delivery of cytokine genes using a DNA prime-protein boost strategy Scheerlinck, Jean-Pierre Y.
 2001
 19 28-29 p. 4053-4060
8 p.
 article
37 Three double-blind, randomized trials evaluating the safety and tolerance of different formulations of the saponin adjuvant QS-21 Waite, Douglas C
 2001
 19 28-29 p. 3957-3967
11 p.
 article
                             37 results found
 
 Koninklijke Bibliotheek - National Library of the Netherlands